Navigation Links
eResearchTechnology Reports Third Quarter 2008 Results
Date:10/30/2008

(62,190) (62,190)

Total stockholders' equity 113,512 135,952

Total liabilities and

stockholders' equity $147,696 $166,325

eResearchTechnology, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

Nine Months Ended September 30,

2007 2008

Operating activities:

Net income $10,093 $19,336

Adjustments to reconcile net

income to net cash provided

by operating activities:

Depreciation and amortization 11,066 12,519

Cost of sales of equipment 1,004 717

Provision for

uncollectible accounts - 60

Share-based compensation 1,576 1,966

Deferred income taxes 482 (1,151)

Changes in operating assets

and liabilities excluding CCSS

acquisition:

Accounts receivable (3,777) (6,601)

Prepaid expenses and other (595) (1,560)

Accounts payable (1,888) 357

Accrued expenses 1,500 (540)

Income taxes 2,267 931

Deferred revenues 995 747

Net cash provided by

operating activities 22,723 26,781 '/>"/>

SOURCE eResearchTechnology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
2. eResearchTechnology to Present at the UBS Global Healthcare Services Conference 2008 on February 11th
3. eResearchTechnology, Inc. to Announce 2007 Fourth Quarter Results on February 26, 2008
4. eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results
5. eResearchTechnology, Inc. and nSpire Health, Inc. Form Alliance to Deliver Integrated Cardiac Safety and Pulmonary Clinical Trial Services
6. eResearchTechnology, Inc. to Announce 2008 First Quarter Results on May 5, 2008
7. eResearchTechnology to Present at the Deutsche Bank 33rd Annual Healthcare Conference on May 7th 2008
8. eResearchTechnology Reports First Quarter 2008 Results
9. eResearchTechnology Announces Resignation of its CFO
10. eResearchTechnology to Present at the FBR 12th Annual Spring Investor Conference on May 28th 2008
11. eResearchTechnology Names New Chief Financial Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)....,Nov.24/PRNewswire/--Twomoreprestigiousuniversiti...nejobboardandcareerssiteforlifescienceprofessional...mbersofthejobboard,joining28othermajorlifesciencet...eercenter.com ,isonlyforpost-graduatesinthelifesci...sontheInternet,BioCareerCenteristheonlyonethatserv...
(Date:11/24/2009).../PRNewswire-FirstCall/--Sigma-AldrichCorporation(N...nceonTuesday,December1stat1:45PMGMTinLondon,7:45AM...castovertheInternetavailableat http://inve s to...cast"icontoaccessthisfile. ,, AboutSigma-Aldr...hnologycompany.Itschemicalandbiochemicalproductsan...
(Date:11/24/2009).../PRNewswire-Asia/--NODPharmaceuticalsInc.announced...patentapplicationfor,itsnano-particleoraldeliveryo...ientapproachtoincorporatepeptidesor,proteinsintobi...s,otherwiseadministeredasinjections.NODtechnologyi...leculardrugssuchasinsulin,interferon,growthhormon...
(Date:11/24/2009)...PRNewswire/--BlueMarbleEnergyCorp.announcedtodayth...(OPDA)wererecentlyawarded$2millionbyWashingtonStat...ivate/publicpartnershiptoconstructthestate,sfirsts...,, "Thisinvestmentwillsignificantlyspeedthedeve...ncolnCounty,"saidBlueMarbleEnergyCEOKellyOgilvie."...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
... Accera, Inc., a biotechnology company delivering...(CNS) disorders, today announced that the company ...nvestor conferences. , , Dr. Steve Orndorff, Fou...ual BIO Venture Conference on April 1 at 10:15 a.m...On April 9 at 11:30 a.m. PDT, he will present at t...
...arch 25 InNexus Biotechnology Inc., (OTC Bulletin...o.com ), a drug development company commercializin...ed on its Dynamic Cross Linking (DXL) technology, ...d into a loan facility with a group of investors f..., , The loan facility, subject to final approval ...
...a., March 25 Human Genome Sciences, Inc. (Nasdaq:...Eisai Corporation of North America, today announce...iscover, develop and commercialize therapeutic mon...mmunology that specifically target antigens discov...gi-bin/prnh/20080416/HGSLOGO ) , , "The rapid co...
Other Biology Technology:Accera, Inc. to Present at Upcoming Investor Conferences 2InNexus Biotechnology Announces a Loan Facility of up to USD$2.5 Million 2Human Genome Sciences and Morphotek(R), Inc. Announce Collaboration to Discover, Develop and Commercialize Antibodies for Oncology and Immunology 2Human Genome Sciences and Morphotek(R), Inc. Announce Collaboration to Discover, Develop and Commercialize Antibodies for Oncology and Immunology 3Human Genome Sciences and Morphotek(R), Inc. Announce Collaboration to Discover, Develop and Commercialize Antibodies for Oncology and Immunology 4Human Genome Sciences and Morphotek(R), Inc. Announce Collaboration to Discover, Develop and Commercialize Antibodies for Oncology and Immunology 5
(Date:11/25/2009)...n, a hormone produced in the stomach, may be used ...f Parkinson,s disease, Yale School of Medicine res...ssue of the Journal of Neuroscience . , Parkins...ne neurons in an area of the midbrain known as the...ne production. Reduced production of dopamine in ...
(Date:11/25/2009)...tember 11, firefighters, police officers and ambul...he World Trade Center complex. They battled to sav... for survivors, tackled fires and evacuated as man...an estimated 17,000 people. And making their jobs ...: frightened workers and their relatives jammed mo...
(Date:11/25/2009)...N, WI, NOVEMBER 25, 2009 Soil is the linchpin of ...hydrosphere meet. Despite that, many students see ...othing more. Soil science educators are challenged...recognize the critical importance of soil in the e...cience and earth science teachers at University of...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2Magic box for mission impossible 2Magic box for mission impossible 3It's not just dirt! 2ULURU Inc to Raise 241 5 Million in Registered Direct Offering 61229 1ULURU Inc to Raise 241 5 Million in Registered Direct Offering 61229 2U S News Media Group and NCQA Release 2009 10 Rankings of Americas Best Health Insurance Plans 61224 1U S News Media Group and NCQA Release 2009 10 Rankings of Americas Best Health Insurance Plans 61224 2U S News Media Group and NCQA Release 2009 10 Rankings of Americas Best Health Insurance Plans 61224 3U S News Media Group and NCQA Release 2009 10 Rankings of Americas Best Health Insurance Plans 61224 4Fred Hassan Joins Bausch 26amp 3B Lomb Board of Directors 61219 1Fred Hassan Joins Bausch 26amp 3B Lomb Board of Directors 61219 2
...ax Delbrck Center for Molecular Medicine (MDC) Ber...n (Germany) have identified a gene which enables t...ility if colon cancer is going to metastasize. Ass... M. Schlag, and Professor Walter Birchmeier were a...-Associated in Colon Cancer 1) not only promotes t...
... Service Southern Research Station (SRS) Fisheries...the Presidential Early Career Award for Scientists...e House. Haag was among the nearly 70 scientists a...hest honor that a young scientist or engineer can ... Early Career Award for Scientists and Engineers, ...
...creases in wind strength along the California coas...tense upwelling of cold water along the coast earl...ern California, according to researchers at the Cl...ity of California, Santa Cruz. , Earth scientist... titled "Future Changes in Surface Winds in the We...
Other Biology News:Newly identified gene powerful predictor of colon cancer metastasis 2Haag honored with Presidential Early Career Scientists Award 2Stronger coastal winds due to climate change may have far-reaching effects 2
...t, Exonuclease Minus, is a DNA-dependent DNA polym...d the 3´→5´ exonuclease activities... It is used for random primer labeling (3,4) and i...agment, Exonuclease Minus, will leave a single-bas...
...es produced from arachidonic acid during lipid per... the rat. 8-iso PGE2 inhibits U-46619 or I-BOP-ind...and 5 µM, respectively. When infused into t... mg/kg/min, 8-iso PGE2 decreases the GFR and renal...
DNA Polymerase I Large (Klenow) Fragment from Invitrogen
...e offers both high-speed and high-volume versatil...s, making it ideal for a wide variety of laborator...gh-speed (up to 15,000 rpm and 21,000 xg) angle ro...tors , Accommodates tube volumes from .25 to 250...
Biology Products: